Shionogi & Co., Ltd. (OTCMKTS:SGIOF) Shares Down 9.2% – Time to Sell?

Shionogi & Co., Ltd. (OTCMKTS:SGIOF) shares were down 9.2% during trading on Monday . The company traded as low as $21.45 and last traded at $21.45. Approximately 971 shares were traded during mid-day trading, an increase of 47% from the average daily volume of 661 shares. The stock had previously closed at $23.63.

Shionogi & Co., Ltd. Stock Performance

The firm has a fifty day simple moving average of $21.43 and a 200-day simple moving average of $18.42.

Shionogi & Co., Ltd. Company Profile

Shionogi & Co, Ltd. is a research-driven pharmaceutical company headquartered in Osaka, Japan, with origins dating back to 1878. The company concentrates on the discovery, development and sale of prescription medicines in key therapeutic areas, including infectious diseases, pain management, cardiovascular and metabolic disorders, central nervous system disorders and oncology. Shionogi’s mission emphasizes addressing unmet medical needs, particularly in the field of antimicrobial resistance, where it has developed both small-molecule antibiotics and novel treatment approaches.

The firm’s product portfolio comprises marketed therapies such as Cresemba (isavuconazole) for invasive fungal infections, and Fetroja (cefiderocol), a siderophore cephalosporin antibiotic for multidrug-resistant Gram-negative infections.